| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 984 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 894 |
| 2 | TACROLIMUS OINTMENT 0.1% | 894 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 725 |
| 4 | MYCOPHENOLATE MOFETIL | 723 |
| 5 | PREDNISONE | 714 |
| 6 | METHYLPREDNISOLONE | 668 |
| 7 | CYCLOPHOSPHAMIDE | 533 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 533 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 533 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANCOMYCIN HYDROCHLORIDE | 425 | 0.0508 |
| 1 | ALUMINUM ACETATE | 2 | 0.0488 |
| 2 | ANIDULAFUNGIN | 51 | 0.0313 |
| 3 | SEROTONIN | 8 | 0.0294 |
| 4 | ERAVACYCLINE | 7 | 0.0235 |
| 5 | AMPICILLIN AND SULBACTAM | 14 | 0.0159 |
| 6 | SILTUXIMAB | 9 | 0.0139 |
| 7 | BASILIXIMAB | 161 | 0.0135 |
| 8 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 3 | 0.0132 |
| 9 | IMIPENEM AND CILASTATIN SODIUM | 27 | 0.0127 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1843 |
| 1 | Alkylating Drug [EPC] | 660 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 518 |
| 3 | Azole Antifungal [EPC] | 495 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 432 |
| 5 | Glycopeptide Antibacterial [EPC] | 424 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 354 |
| 7 | Penem Antibacterial [EPC] | 337 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 336 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 333 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 123 | 0.0150 |
| 1 | Interleukin-6 Antagonist [EPC] | 9 | 0.0139 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 257 | 0.0115 |
| 3 | CD33-directed Immunoconjugate [EPC] | 38 | 0.0104 |
| 4 | Penem Antibacterial [EPC] | 337 | 0.0098 |
| 5 | Tetracycline-class Antibacterial [EPC] | 74 | 0.0094 |
| 6 | Macrolide Antibacterial [EPC] | 9 | 0.0089 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 109 | 0.0085 |
| 8 | Interferon gamma Blocker [EPC] | 2 | 0.0084 |
| 9 | Lipopeptide Antibacterial [EPC] | 78 | 0.0082 |